The Federal Trade Commission said Friday that it is suing three drug middlemen, accusing them of inflating insulin prices.

(AP) — The federal government is suing some big pharmacy benefit managers, or PBMs, over a system of drug rebates that ...

The Federal Trade Commission filed an action against the three largest prescription drug benefit managers or PBMs— CVS Health's ...

Few medications have become as popular and culturally relevant as Ozempic has, but how exactly do it and similar drugs affect ...

Friday initiated legal action against the three largest prescription drug benefit managers (PBMs) in the U.S.—Caremark Rx, ...

The latest health news covers the European Medicines Agency supporting Novo Nordisk’s drug for heart failure in obese ...

High demand for weight-loss and diabetes drugs like Ozempic and Wegovy has led to a shortage in manufacturing. In the ...

The Federal Trade Commission took action Friday against the nation’s three largest pharmacy benefit managers, accusing the ...

CelluCare Blood Sugar Support Formula helps regulate glucose levels, improve insulin sensitivity, and reduce sugar cravings ...

Recent health developments include the EU backing Novo Nordisk's Wegovy for obesity-related heart conditions, FDA approvals ...

The agency alleges CVS’s Caremark, Cigna’s Express Scripts and UnitedHealth’s Optum Rx accepted money from drugmakers in ...

The agency says the companies artificially inflated insulin list prices that resulted in patients paying more for the medications. The companies are CVS Health’s Caremark RX, Cigna’s Express Scripts, ...